{
    "Section VI": [
        "Pharmacology and Pharmacologic Modalities",
        {
            "Q31": {
                "desc": "Major Opioids in Pain Management",
                "question": "Match the opioid with its typical use.",
                "label": ["Opioid", "Typical Use"],
                "option": ["Morphine", "Fentanyl", "Oxycodone", "Hydrocodone"],
                "options": {
                    "A": "Severe pain",
                    "B": "Chronic pain",
                    "C": "Postoperative pain",
                    "D": "Moderate to severe pain"
                }
            },
            "Q32": {
                "desc": "Opioids Used for Mild to Moderate Pain",
                "question": "Match the opioid with its common indication.",
                "label": ["Opioid", "Common Indication"],
                "option": ["Codeine", "Tramadol", "Hydrocodone", "Buprenorphine"],
                "options": {
                    "A": "Mild to moderate pain",
                    "B": "Moderate pain",
                    "C": "Moderate to severe pain",
                    "D": "Pain management and addiction treatment"
                }
            },
            "Q33": {
                "desc": "The Prescription Drug Abuse Epidemic and Emerging Prescribing Guidelines",
                "question": "Match the guideline with its purpose in reducing opioid abuse.",
                "label": ["Guideline", "Purpose"],
                "option": ["CDC Guideline for Prescribing Opioids", "FDA REMS", "State PDMPs", "Opioid contracts"],
                "options": {
                    "A": "Providing safer prescribing practices",
                    "B": "Monitoring medication risks",
                    "C": "Tracking prescription data",
                    "D": "Establishing patient-provider agreements"
                }
            },
            "Q34": {
                "desc": "Legal and Regulatory Issues in Pain Management",
                "question": "Match the regulatory body with its role in pain management.",
                "label": ["Regulatory Body", "Role"],
                "option": ["DEA", "FDA", "CMS", "State medical boards"],
                "options": {
                    "A": "Enforcing controlled substance laws",
                    "B": "Regulating medications",
                    "C": "Overseeing Medicare and Medicaid",
                    "D": "Licensing and regulating physicians"
                }
            },
            "Q35": {
                "desc": "Urine Drug Testing in Pain Medicine",
                "question": "Match the urine drug test result with its interpretation.",
                "label": ["Test Result", "Interpretation"],
                "option": ["Positive for prescribed opioid", "Positive for non-prescribed drug", "Negative for prescribed opioid", "Positive for metabolites"],
                "options": {
                    "A": "Patient is adherent to treatment",
                    "B": "Possible substance abuse",
                    "C": "Possible non-adherence",
                    "D": "Confirming medication metabolism"
                }
            },
            "Q36": {
                "desc": "Substance Use Disorders and Detoxification",
                "question": "Match the detoxification method with its substance use disorder.",
                "label": ["Detoxification Method", "Substance Use Disorder"],
                "option": ["Methadone", "Buprenorphine", "Benzodiazepines", "Nicotine replacement therapy"],
                "options": {
                    "A": "Opioid dependence",
                    "B": "Opioid dependence",
                    "C": "Alcohol dependence",
                    "D": "Tobacco dependence"
                }
            },
            "Q37": {
                "desc": "Psychopharmacology for Pain Medicine",
                "question": "Match the psychotropic medication with its pain management use.",
                "label": ["Medication", "Pain Management Use"],
                "option": ["Antidepressants", "Anticonvulsants", "Anxiolytics", "Antipsychotics"],
                "options": {
                    "A": "Neuropathic pain",
                    "B": "Chronic pain",
                    "C": "Anxiety-related pain",
                    "D": "Severe pain with psychosis"
                }
            },
            "Q38": {
                "desc": "Membrane Stabilizers",
                "question": "Match the membrane stabilizer with its primary effect on pain.",
                "label": ["Membrane Stabilizer", "Primary Effect"],
                "option": ["Gabapentin", "Pregabalin", "Carbamazepine", "Lidocaine"],
                "options": {
                    "A": "Reducing neuropathic pain",
                    "B": "Decreasing nerve excitability",
                    "C": "Treating trigeminal neuralgia",
                    "D": "Providing local anesthesia"
                }
            },
            "Q39": {
                "desc": "Recommendations for Pharmacologic Therapy of Neuropathic Pain",
                "question": "Match the recommended drug class with its example for neuropathic pain.",
                "label": ["Drug Class", "Example"],
                "option": ["Anticonvulsants", "Antidepressants", "Opioids", "Topical agents"],
                "options": {
                    "A": "Gabapentin",
                    "B": "Amitriptyline",
                    "C": "Morphine",
                    "D": "Capsaicin"
                }
            }
        }
    ]
}